Lavanya Vijayasingham, Shirin Heidari, Jean Munro, Saad Omer, Noni MacDonald
Human Vaccines & Immunotherapeutics – January 25, 2022
The influence of sex and gender in immune response and vaccine outcomes is established in many disease areas, including in COVID-19. Yet, there are notable gaps in the consideration of sex and gender in the analysis and reporting of COVID-19 vaccines clinical trial data. The push for stronger sex and gender integration in vaccines science should be championed by all researchers and stakeholders across the R&D and access ecosystem – not just gender experts.